{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:43:00Z","timestamp":1792636980957,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-034638"],"award-info":[{"award-number":["INV-034638"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP5OD033362"],"award-info":[{"award-number":["DP5OD033362"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006369","name":"George Mason University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006961","name":"California Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006961","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cell.2023.04.024","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T19:28:16Z","timestamp":1682105296000},"page":"2380-2391.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4923-9568","authenticated-orcid":false,"given":"Magnus A.G.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Huey-Tubman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanthi N.P.","family":"Gnanapragasam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leesa M.","family":"Nakatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya N.","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woohyun J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo J.C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Anthony P.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2277-3990","authenticated-orcid":false,"given":"Pamela J.","family":"Bjorkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2023.04.024_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2023.04.024_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cell.2023.04.024_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","article-title":"Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses","volume":"23","author":"Chen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2023.04.024_bib4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41577-022-00716-1","article-title":"Disentangling the relative importance of T\u00a0cell responses in COVID-19: leading actors or supporting cast?","volume":"22","author":"Kent","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2023.04.024_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA vaccines in the COVID-19 pandemic and beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present yourself! By MHC class I and MHC Class II molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cell.2023.04.024_bib9","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1\u20132 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib11","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cell.2023.04.024_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00455-3","article-title":"Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines","volume":"7","author":"Karbiener","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.cell.2023.04.024_bib13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra2206573","article-title":"Covid-19 vaccines - immunity, variants, boosters","volume":"387","author":"Barouch","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib15","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJMc2102179","article-title":"Serum neutralizing activity elicited by mRNA-1273 vaccine","volume":"384","author":"Wu","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2206576","article-title":"Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5","volume":"387","author":"Hachmann","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib17","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1126\/science.1162042","article-title":"Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55","volume":"322","author":"Lee","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.04.024_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-cellbio-100616-060600","article-title":"Structures, functions, and dynamics of ESCRT-III\/Vps4 membrane remodeling and fission complexes","volume":"34","author":"McCullough","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.cell.2023.04.024_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.chom.2013.08.012","article-title":"Virus budding and the ESCRT pathway","volume":"14","author":"Votteler","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2023.04.024_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2023.04.024_bib22","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.04.024_bib23","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/JVI.02146-06","article-title":"The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein","volume":"81","author":"McBride","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2023.04.024_bib24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2007.01.035","article-title":"Structural and biochemical studies of ALIX\/AIP1 and its role in retrovirus budding","volume":"128","author":"Fisher","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cell.2023.04.024_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2217\/fvl.15.6","article-title":"The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target","volume":"10","author":"Madara","year":"2015","journal-title":"Future Virol."},{"key":"10.1016\/j.cell.2023.04.024_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.virol.2009.06.016","article-title":"Functional role of Alix in HIV-1 replication","volume":"391","author":"Fujii","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.cell.2023.04.024_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0092-8674(89)90846-5","article-title":"Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity","volume":"58","author":"Miettinen","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.cell.2023.04.024_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2023.04.024_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.997875","article-title":"How promising are HIV-1-based virus-like particles for medical applications","volume":"12","author":"Martins","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cell.2023.04.024_bib29","doi-asserted-by":"crossref","first-page":"18719","DOI":"10.1073\/pnas.2010320117","article-title":"Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells","volume":"117","author":"Hoffmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.04.024_bib30","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.abl6184","article-title":"Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles","volume":"374","author":"Syed","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.04.024_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/acscentsci.0c01405","article-title":"A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice","volume":"7","author":"Powell","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.cell.2023.04.024_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110143","article-title":"SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity","volume":"37","author":"Joyce","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2023.04.024_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","article-title":"Structures and distributions of SARS-CoV-2 spike proteins on intact virions","volume":"588","author":"Ke","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2023.04.024_bib34","doi-asserted-by":"crossref","first-page":"26523","DOI":"10.1073\/pnas.1909653116","article-title":"Approaching infinite affinity through engineering of peptide\u2013protein interaction","volume":"116","author":"Keeble","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.04.024_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00393-6","article-title":"Scientific rationale for developing potent RBD-based vaccines targeting COVID-19","volume":"6","author":"Kleanthous","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.cell.2023.04.024_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003991","article-title":"Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study","volume":"19","author":"van Gils","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.cell.2023.04.024_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","article-title":"FluBlok, a next generation influenza vaccine manufactured in insect cells","volume":"37","author":"Cox","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.cell.2023.04.024_bib38","series-title":"Molecular Biology of the Cell","author":"Alberts","year":"2002"},{"key":"10.1016\/j.cell.2023.04.024_bib39","article-title":"Predicting the efficacy of variant-modified COVID-19 vaccine boosters","author":"Khoury","year":"2022","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.cell.2023.04.024_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4939-1158-5_6","article-title":"CTL ELISPOT assay","volume":"1186","author":"Ranieri","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cell.2023.04.024_bib41","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.4161\/cc.8.22.10047","article-title":"Cep55 stabilization is required for normal execution of cytokinesis","volume":"8","author":"van der Horst","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cell.2023.04.024_bib42","article-title":"Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens","volume":"3","author":"Kraft","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib43","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/emboj\/21.10.2397","article-title":"Structure and functional interactions of the Tsg101\u00a0UEV domain","volume":"21","author":"Pornillos","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2023.04.024_bib44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.116.4.875","article-title":"Fc receptor endocytosis is controlled by a cytoplasmic domain determinant that actively prevents coated pit localization","volume":"116","author":"Miettinen","year":"1992","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.cell.2023.04.024_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","article-title":"mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant","volume":"28","author":"Gruell","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2023.04.024_bib46","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41422-020-00392-7","article-title":"A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice","volume":"30","author":"Lu","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2023.04.024_bib47","article-title":"The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2023.04.024_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.13091","article-title":"Correlates of protection against SARS-CoV-2 infection and COVID-19 disease","volume":"310","author":"Goldblatt","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cell.2023.04.024_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj0299","article-title":"Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"373","author":"Corbett","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.04.024_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.04.024_bib51","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.04.024_bib52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2023.04.024_bib53","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","article-title":"Production of high-titer helper-free retroviruses by transient transfection","volume":"90","author":"Pear","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.04.024_bib75","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","article-title":"ImageJ2: ImageJ for the next generation of scientific image data","volume":"18","author":"Rueden","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cell.2023.04.024_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.cell.2023.04.024_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jsb.2016.07.011","article-title":"Automated tilt series alignment and tomographic reconstruction in IMOD","volume":"197","author":"Mastronarde","year":"2017","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.cell.2023.04.024_bib56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.cell.2023.04.024_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.cell.2023.04.024_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nmeth.3204","article-title":"cellPACK: a virtual mesoscope to model and visualize structural systems biology","volume":"12","author":"Johnson","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2023.04.024_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1039\/C4FD00017J","article-title":"3D molecular models of whole HIV-1 virions generated with cellPACK","volume":"169","author":"Johnson","year":"2014","journal-title":"Faraday Discuss."},{"key":"10.1016\/j.cell.2023.04.024_bib60","doi-asserted-by":"crossref","first-page":"10598","DOI":"10.1073\/pnas.1309215110","article-title":"Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues","volume":"110","author":"West","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.04.024_bib61","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.04.024_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq0839","article-title":"Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models","volume":"377","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.04.024_bib63","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.immuni.2022.04.003","article-title":"Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins","volume":"55","author":"Wang","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2023.04.024_bib64","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2023.04.024_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/srep19234","article-title":"Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2023.04.024_bib66","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.04.024_bib67","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.04.024_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jsb.2016.06.007","article-title":"Implementation of a cryo-electron tomography tilt-scheme optimized for high resolution subtomogram averaging","volume":"197","author":"Hagen","year":"2017","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.cell.2023.04.024_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2023.04.024_bib70","doi-asserted-by":"crossref","first-page":"599587","DOI":"10.3389\/fimmu.2020.599587","article-title":"CoVaccine HT adjuvant potentiates robust immune responses to recombinant SARS-CoV-2 spike S1 immunization","volume":"11","author":"Haun","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2023.04.024_bib71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent Endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cell.2023.04.024_bib72","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cell.2023.04.024_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2023.04.024_bib74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J.\u00a0Control. Release"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867423004208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867423004208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:23:59Z","timestamp":1786217039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867423004208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0092867423004208"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2023.04.024","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2023.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}